Consultant Dermatologist, Dr. Dashore's DHL Clinic, Indore, MP
|How to cite this article:
Dashore S. Author's reply. Indian J Dermatol Venereol Leprol 2019;85:412-413
I would like to thank you for your interest in our case of two rare variants of dermatofibrosarcoma protuberans. You have rightly pointed out that there is an increased prevalence of this condition in HIV seropositive cases. However, case 1 described in the letter to the editor had persistent slowly progressive lesion since the past 25 years with no history suggestive of HIV seropositivity occurring before the appearance of lesion and progression of the same over the period of 25 years. You have also rightly stated that the incidence of HIV seroprevalence in India is higher than global average. However, the case in discussion hails from Madhya Pradesh which is a low prevalence state for HIV. Prevalence of HIV seropositivity in blood donors in the state of Madhya Pradesh was found to be 0.10%, which is lower than the global average (0.2%). In view of the above factors, HIV testing was not undertaken. We agree with the argument that HIV testing must be done in cases of atypical cases of dermatofibrosarcoma protuberans especially in areas of high prevalence of HIV.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
Sapadin AN, Gelfand JM, Howe KL, Phelps RG, Grand D, Rudikoff D, et al. Dermatofibrosarcoma protuberans in two patients with acquired immunodeficiency syndrome. Cutis 2000;65:85-8.[Google Scholar]
Jain S, Dashore S, Singhania B, Khopkar US, Darkase B. Dermatofibrosarcoma protuberans: Two rare variants. Indian J Dermatol Venereol Leprol 2019;85:204-8.[Google Scholar]
Paranjape RS, Challacombe SJ. HIV/AIDS in India: An overview of the Indian epidemic. Oral Dis 2016;22 Suppl 1:10-4.[Google Scholar]
Yadav UC, Sharma D, Shrivatava M, Jain A. Prevalence of HIV among blood donors at Madhya Pradesh, a central state of India. IOSR J Dent Med Sci 2018;17:57-64.[Google Scholar]